Diagnostic tools for hypertension and salt sensitivity testing

Current Opinion in Nephrology and Hypertension

Volumn 22, Issue 1, 2013, Pages 65-76

  Felder, Robin A ^a   White, Marquitta J ^b,c   Williams, Scott M ^b,c   Jose, Pedro A ^d  

^a UNIVERSITY OF VIRGINIA   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

renal proximal tubule cell; salt sensitivity; urine exosomes

Indexed keywords

ANGIOTENSINOGEN; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; FENOLDOPAM; G PROTEIN COUPLED RECEPTOR KINASE 4; OUABAIN; RENIN; SODIUM CHLORIDE;

CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; DISEASE MARKER; ENVIRONMENTAL FACTOR; EXOSOME; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; HYPERTENSION; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; MEAN ARTERIAL PRESSURE; MORBIDITY; NONHUMAN; PATIENT COMPLIANCE; PHARMACOGENOMICS; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; REVIEW; SALT INTAKE; SALT SENSITIVITY; SEDENTARY LIFESTYLE; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; URINALYSIS;

BIOLOGICAL MARKERS; BLOOD PRESSURE; EXOSOMES; G-PROTEIN-COUPLED RECEPTOR KINASE 4; GENETIC TESTING; HUMANS; HYPERTENSION; KIDNEY TUBULES, PROXIMAL; SODIUM CHLORIDE, DIETARY;

EID: 84871773091     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32835b3693     Document Type: Review

References (113)

1. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet 2003; 361:598-604.
2. Li M, Reilly MP, Rader DJ, Wang LS. Correcting population stratification in genetic association studies using a phylogenetic approach. Bioinformatics 2010; 26:798-806.
3. Lifton RP. Genetic dissection of human blood pressure variation: common pathways from rare phenotypes. Harvey Lect 2004-2005; 100:71-101.
4. Boyden LM, Choi M, Choate KA, et al. Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature 2012; 482:98-102.
5. Alwan A, editor. Global Status Report on noncommunicable diseases 2010., World Health Organization; 2011. ISBN 978-92-4-068645-8.
6. World health statistics 2012. Switzerland: WHO Press, World Health Organization.
7. Centers for Disease Control and Prevention (CDC). Vital signs: awareness and treatment of uncontrolled hypertension among adults-United States, 2003-2010. MMWR Morb Mortal Wkly Rep 2012; 61:703-709.
8. Weinberger MH, Fineberg NS, Fineberg SE, Weinberger M. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension 2001; 37 (2 Part 2):429-432.
9. Frisoli TM, Schmieder RE, Grodzicki T, Messerli FH. Salt and hypertension: is salt dietary reduction worth the effort? Am J Med 2012; 125:433-439.
10. De Wardener HE, MacGregor GA. Harmful effects of dietary salt in addition to hypertension. J Hum Hypertens 2002; 16:213-223.
11. Franco V, Oparil S. Salt sensitivity, a determinant of blood pressure, cardiovascular disease and survival. J Am Coll Nutr 2006; 25 (3 Suppl.):247S-255S.
12. Cutler JA, Sorlie PD, Wolz M, et al. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 2008; 52:818-827.
13. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010; 303:2043-2050.
14. Hajjar I, Kotchen JM, Kotchen TA. Hypertension: trends in prevalence, incidence, and control. Annu Rev Public Health 2006; 27:465-490.
15. Chobanian AV, Bakris GL, Black HR, et al., Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252.
16. Agarwal R, Bills JE, Hecht TJ, Light RP. Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis. Hypertension 2011; 57:29-38.
17. Ward AM, Takahashi O, Stevens R, Heneghan C. Home measurement of blood pressure and cardiovascular disease: systematic review and metaanalysis of prospective studies. J Hypertens 2012; 30:449-456.
18. Viera AJ, Lin FC, Hinderliter AL, et al. Nighttime blood pressure dipping in young adults and coronary artery calcium 10-15 years later: the coronary artery risk development in young adults study. Hypertension 2012; 59:1157-1163.
19. Muntner P, Shimbo D, Tonelli M, et al. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension 2011; 57:160-166.
20. Johansson JK, Niiranen TJ, Puukka PJ, Jula AM. Prognostic value of the variability in home-measured blood pressure and heart rate: the Finn-Home Study. Hypertension 2012; 59:212-218.
21. O'Brien E, Atkins N, Stergiou G, et al., Working Group on Blood Pressure Monitoring of the European Society of Hypertension. European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults. Blood Press Monit 2010; 15:23-38.
22. Alpert BS. Validation of the Welch Allyn SureBP (inflation) and StepBP (deflation) algorithms by AAMI standard testing and BHS data analysis. Blood Press Monit 2011; 16:96-98.
23. Sullivan JM. Salt sensitivity. Definition, conception, methodology, and longterm issues. Hypertension 1991; 17 (1 Suppl.):I61-I68.
24. De la Sierra A, Giner V, Bragulat E, Coca A. Lack of correlation between two methods for the assessment of salt sensitivity in essential hypertension. J Hum Hypertens 2002; 16:255-260.
25. Yatabe MS, Yatabe J, Yoneda M, et al. Salt sensitivity is associated with insulin resistance, sympathetic overactivity, and decreased suppression of circulating renin activity in lean patients with essential hypertension. Am J Clin Nutr 2010; 92:77-82.
26. Nichols J, Elijovich F, Laffer CL. Lack of validation of a same-day outpatient protocol for determination of salt sensitivity of blood pressure. Hypertension 2012; 59:390-394.
27. Institute of Medicine. Strategies to reduce sodium intake in the United States. Washington, D.C.: The National Academic Press, U.S. Department of Agriculture, U.S. Department of Health and Human Services/Washington, D.C.: Government Publishing Office; 2010.
28. Ezzati M, Riboli E. Can noncommunicable diseases be prevented? Lessons from studies of populations and individuals. Science 2012; 337:1482-1487.
29. Taylor RS, Ashton KE, Moxham T, et al. Reduced dietary salt for the prevention of cardiovascular disease. Cochrane Database Syst Rev 2011; (7):CD009217.
30. Dorresteijn JA, van der Graaf Y, Spiering W, et al., Secondary Manifestations of Arterial Disease Study Group. Relation between blood pressure and vascular events and mortality in patients with manifest vascular disease: J-curve revisited. Hypertension 2012; 59:14-21.
31. O'Donnell MJ, Yusuf S, Mente A, et al. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA 2011; 306:2229-2238.
32. Alderman MH, Cohen HW. Dietary sodium intake and cardiovascular mortality: controversy resolved? Curr Hypertens Rep 2012; 14:193-201.
33. Stolarz-Skrzypek K, Kuznetsova T, Thijs L, et al., European Project on Genes in Hypertension (EPOGH) Investigators. Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA 2011; 305:1777-1785.
34. Carey RM, Schoeffel CD, Gildea JJ, et al. Salt sensitivity of blood pressure is associated with polymorphisms in the sodium-bicarbonate cotransporter. Hypertension 2012; 60:1359-1366.
35. Uzu T, Kimura G, Yamauchi A, et al. Enhanced sodium sensitivity and disturbed circadian rhythm of blood pressure in essential hypertension. J Hypertens 2006; 24:1627-1632.
36. Simonetti GD, Farese S, Aregger F, et al. Nocturnal dipping behaviour in normotensive white children and young adults in response to changes in salt intake. J Hypertens 2010; 28:1027-1033.
37. Kato N, Kanda T, Sagara M, et al. Proposition of a feasible protocol to evaluate salt sensitivity in a population-based setting. Hypertens Res 2002; 25:801-809.
38. Fisher ND, Hurwitz S, Jeunemaitre X, et al. Familial aggregation of low-renin hypertension. Hypertension 2002; 39:914-918.
39. Sanada H, Yatabe J, Midorikawa S, et al. Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. Clin Chem 2006; 52:352-360.
40. Pimenta E, Gaddam KK, Oparil S, et al. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension 2009; 54:475-481.
41. Yatabe MS, Yoneda M, Felder RA, et al. Hypertension-related gene polymorphisms of G-protein-coupled receptor kinase 4 are associated with NT-proBNP concentration in normotensive healthy adults. Int J Hypertens 2012; 2012:806810.
42. Blaustein MP, Leenen FH, Chen L, et al. How NaCl raises blood pressure: a new paradigm for the pathogenesis of salt-dependent hypertension. Am J Physiol Heart Circ Physiol 2012; 302:H1031-H1049.
43. Gildea JJ, Lahiff DT, Keene SA, et al. A rapid method for clinical diagnosis of salt sensitivity of blood pressure. High Blood Pressure Research, 2012 Scientific Sessions. Abstract #32, pp. 38-39.
44. Carlson JM, Gildea JJ, Schoeffel CD, et al. Urinary exosome miRNome analysis and its application to salt sensitivity of blood pressure. High Blood Pressure Research, 2012 Scientific Sessions. Abstract #30, p. 38.
45. Carlson JM, Gildea JJ, Pettigrew AC, et al. Exosomes as potential acellular signaling mechanism in the kidney. High Blood Pressure Research, 2012 Scientific Sessions. Abstract #481, p. 162.
46. Alvarez ML, Khosroheidari M, Kanchi Ravi R, Distefano JK. Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. Kidney Int 2012. doi: 10.1038/ki.2012.256. [Epub ahead of print]
47. Wang G, Tam LS, Li EK, et al. Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus. J Rheumatol 2010; 37:2516-2522.
48. Harrap SB. Blood pressure genetics: time to focus. J Am Soc Hypertens 2009; 3:231-237.
49. King DE, Mainous AG 3rd, Carnemolla M, Everett CJ. Adherence to healthy lifestyle habits in US adults, 1988-2006. Am J Med 2009; 122:528-534.
50. Ohta Y, Tsuchihashi T, Onaka U, et al. Long-term compliance with salt restriction in Japanese hypertensive patients. Hypertens Res 2005; 28:953-957.
51. Mellen PB, Gao SK, Vitolins MZ, Goff DC Jr. Deteriorating dietary habits among adults with hypertension: DASH dietary accordance, NHANES 1988-1994 and 1999-2004. Arch Intern Med 2008; 168:308-314.
52. Navar LG, Kobori H, Prieto MC, Gonzalez-Villalobos RA. Intratubular renin-angiotensin system in hypertension. Hypertension 2011; 57:355-362.
53. Luft FC. Renin-angiotensin system-related highlights from the High Blood Pressure Research Conference annual meeting. J Renin Angiotensin Aldosterone Syst 2008; 9:242-247.
54. Huang J, Siragy HM. Sodium depletion enhances renal expression of (pro)-renin receptor via cyclic GMP-protein kinase G signaling pathway. Hypertension 2012; 59:317-323.
55. Ferrario CM, Varagic J. The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function. Am J Physiol Renal Physiol 2010; 298:F1297-F1305.
56. Garcia-Espinosa MA, Shaltout HA, Gallagher PE, et al. In vivo expression of angiotensin-(1-7) lowers blood pressure and improves baroreflex function in transgenic (mren2)27 rats. J Cardiovasc Pharmacol 2012; 60:150-157.
57. Padia SH, Carey RM. AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal function. Pflugers Arch 2012. [Epub ahead of print]
58. Jose PA, Soares-da-Silva P, Eisner GM, Felder RA. Dopamine and G proteincoupled receptor kinase 4 in the kidney: role in blood pressure regulation. Biochim Biophys Acta 2010; 398:553-558.
59. Stragier B, Hristova I, Sarre S, et al. In vivo characterization of the angiotensin-( 1-7)-induced dopamine and gamma-aminobutyric acid release in the striatum of the rat. Eur J Neurosci 2005; 22:658-664.
60. Pawlak R, Napiorkowska-Pawlak D, Takada Y, et al. The differential effect of angiotensin II and angiotensin 1-7 on norepinephrine, epinephrine, and dopamine concentrations in rat hypothalamus: the involvement of angiotensin receptors. Brain Res Bull 2001; 54:689-694.
61. Johnson AD, Newton-Cheh C, Chasman DI, et al., Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium; Global BPgen Consortium; Women's Genome Health Study. Association of hypertension drug target genes with blood pressure and hypertension in 86,588 individuals. Hypertension 2011; 57:903-910.
62. Pereira TV, Nunes AC, Rudnicki M, et al. Meta-analysis of the association of 4 angiotensinogen polymorphisms with essential hypertension: a role beyond M235T? Hypertension 2008; 51:778-783.
63. Strazzullo P, Galletti F. Genetics of salt-sensitive hypertension. Curr Hypertens Rep 2007; 9:25-32.
64. Gu D, Kelly TN, Hixson JE, et al. Genetic variants in the renin-angiotensin-aldosterone system and salt sensitivity of blood pressure. J Hypertens 2010; 28:1210-1220.
65. Sanada H, Jones JE, Jose PA. Genetics of salt-sensitive hypertension. Curr Hypertens Rep 2011; 13:55-66.
66. Citterio L, Simonini M, Zagato L, et al. Genes involved in vasoconstriction and vasodilation system affect salt sensitive hypertension. PLoS One 2011; 6:e19620.
67. Blaustein MP, Zhang J, Chen L, et al. The pump, the exchanger, and endogenous ouabain: signaling mechanisms that link salt retention to hypertension. Hypertension 2009; 53:291-298.
68. Zhao Q, Gu D, Hixson JE, et al., Genetic Epidemiology Network of Salt Sensitivity Collaborative Research Group. Common variants in epithelial sodium channel genes contribute to salt sensitivity of blood pressure: the GenSalt study. Circ Cardiovasc Genet 2011; 4:375-380.
69. Rao AD, Sun B, Saxena A, et al. Polymorphisms in the serum-and glucocorticoid-inducible kinase 1 gene are associated with blood pressure and renin response to dietary salt intake. J Hum Hypertens 2012. doi: 10.1038/jhh.2012.22. [Epub ahead of print]
70. Dahlberg J, Nilsson LO, von Wowern F, Melander O. Polymorphism in NEDD4L is associated with increased salt sensitivity, reduced levels of P-renin and increased levels of Nt-proANP. PLoS One 2007; 2:e432.
71. Nicolas HA, Kulik R, Lamothe G, et al. Increased blood pressure in response to salt intake in hypertensive G carriers of the NEDD4L SNP rs4149601. High Blood Pressure Research, 2012 Scientific Sessions. Abstract #28, p. 37.
72. Manunta P, Lavery G, Lanzani C, et al. Physiological interaction between a-adducin and WNK1-NEDD4L pathways on sodium-related blood pressure regulation. Hypertension 2008; 52:366-372.
73. Torielli L, Tivodar S, Montella RC, et al. a-Adducin mutations increase Na/K pump activity in renal cells by affecting constitutive endocytosis: implications for tubular Na reabsorption. Am J Physiol Renal Physiol 2008; 295:F478-F487.
74. Ferrandi M, Molinari I, Torielli L, et al. Adducin-and ouabain-related gene variants predict the antihypertensive activity of rostafuroxin, part 1: experimental studies. Sci Transl Med 2010; 2:59ra86.
75. Wang R, Zhong B, Liu Y, Wang C. Association between a-adducin gene polymorphism (Gly460Trp) and genetic predisposition to salt sensitivity: a meta-analysis. J Appl Genet 2010; 51:87-94.
76. Kelly TN, Rice TK, Gu D, et al. Novel genetic variants in the a-adducin and guanine nucleotide binding protein b-polypeptide 3 genes and salt sensitivity of blood pressure. Am J Hypertens 2009; 22:985-992.
77. Manunta P, Maillard M, Tantardini C, et al. Relationships among endogenous ouabain, a-adducin polymorphisms and renal sodium handling in primary hypertension. J Hypertens 2008; 26:914-920.
78. Fava C, Montagnana M, Almgren P, et al. Association between adducin-1 G460W variant and blood pressure in Swedes is dependent on interaction with body mass index and gender. Am J Hypertens 2007; 20:981-989.
79. Citarella MR, Choi MR, Gironacci MM, et al. Urodilatin and dopamine: a new interaction in the kidney. Regul Pept 2009; 153:19-24.
80. Zeng C, Luo Y, Asico LD, et al. Perturbation of D1 dopamine and AT1 receptor interaction in spontaneously hypertensive rats. Hypertension 2003; 42:787-792.
81. Li H, Armando I, Yu P, et al. Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells. J Clin Invest 2008; 118:2180-2189.
82. Li D, Scott L, Crambert S, et al. Binding of losartan to angiotensin AT1 receptors increases dopamine D1 receptor activation. J Am Soc Nephrol 2012; 23:421-428.
83. Khan F, Spicarová Z, Zelenin S, et al. Negative reciprocity between angiotensin II type 1 and dopamine D1 receptors in rat renal proximal tubule cells. Am J Physiol Renal Physiol 2008; 295:F1110-F1116.
84. Yao B, Harris RC, Zhang MZ. Intrarenal dopamine attenuates deoxycorticosterone acetate/high salt-induced blood pressure elevation in part through activation of a medullary cyclooxygenase 2 pathway. Hypertension 2009; 54:1077-1083.
85. Kirchheimer C, Mendez CF, Acquier A, Nowicki S. Role of 20-HETE in D1/D2 dopamine receptor synergism resulting in the inhibition of Na+-K+-ATPase activity in the proximal tubule. Am J Physiol Renal Physiol 2007; 292:F1435-F1442.
86. Yu C, Yang Z, Ren H, et al. D3 dopamine receptor regulation of ETB receptors in renal proximal tubule cells from WKY and SHRs. Am J Hypertens 2009; 22:877-883.
87. Jiang X, Wang W, Ning B, et al. Basal and postprandial serum levels of gastrin in normotensive and hypertensive adults. Clin Exp Hypertens 2012. [Epub ahead of print]
88. Chen Y, Zhen S, Asico L, et al. Synergistic effects of renal dopamine and gastrin receptors in hypertension. High Blood Pressure Research. 2012 Scientific Sessions. Abstract #341, p. 125.
89. Zeng C, Han Y, Huang H, et al. D1-like receptors inhibit insulin-induced vascular smooth muscle cell proliferation via down-regulation of insulin receptor expression. J Hypertens 2009; 27:1033-1041.
90. Yang J, Cui Z, He D, et al. Insulin increases D5 dopamine receptor expression and function in renal proximal tubule cells from Wistar-Kyoto rats. Am J Hypertens 2009; 22:770-776.
91. Venkatakrishnan U, Chen C, Lokhandwala MF. The role of intrarenal nitric oxide in the natriuretic response to dopamine receptor activation. Clin Exp Hypertens 2000; 22:309-324.
92. Crambert S, Sjö berg A, Eklö f AC, et al. Prolactin and dopamine 1-like receptor interaction in renal proximal tubular cells. Am J Physiol Renal Physiol 2010; 299:F49-F54.
93. Ueda A, Ozono R, Oshima T, et al. Disruption of the type 2 dopamine receptor gene causes a sodium-dependent increase in blood pressure in mice. Am J Hypertens 2003; 16:853-858.
94. Harris RC. Abnormalities in renal dopamine signaling and hypertension: the role of GRK4. Curr Opin Nephrol Hypertens 2012; 21:61-65.
95. Zhang MZ, Yao B, Wang S, et al. Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice. J Clin Invest 2011; 121:2845-2854.
96. Aviv A, Hollenberg NK, Weder A. Urinary potassium excretion and sodium sensitivity in blacks. Hypertension 2004; 43:707-713.
97. Doris PA. Renal proximal tubule sodium transport and genetic mechanisms of essential hypertension. J Hypertens 2000; 18:509-519.
98. Bengra C, Mifflin TE, Khripin Y, et al. Genotyping essential hypertension SNPs using a homogenous PCR method with universal energy transfer primers. Clin Chem 2002; 48:2131-2140.
99. Glazier AM, Nadeau JH, Aitman TJ. Finding genes that underlie complex traits. Science 2002; 298:2345-2349.
100. Wang Z, Asico LD, Escano CS, et al. Human G protein-coupled receptor kinase type 4 g (hGRK4g) wild-type prevents salt sensitivity while its variant, hGRK4g486V, promotes salt sensitivity in transgenic mice: role of genetic background. Hypertension 2006; 48:e27.
101. Wang Z, Escano C, Asico LD, Jose PA. Human GRK4 A486V gene promotes salt sensitivity by impairing D1R function and increasing renal proximal tubular sodium transport in transgenic mice. HBPR 2010 AHA P232.
102. Moore JH, Williams SM. New strategies for identifying gene-gene interactions in hypertension. Ann Med 2002; 34:88-95.
103. Speirs HJ, Katyk K, Kumar NN, et al. Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension. J Hypertens 2004; 22:931-936.
104. Machnik A, Neuhofer W, Jantsch J, et al. Macrophages regulate saltdependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med 2009; 15:545-552.
105. Racusen LC, Fivush BA, Andersson H, Gahl WA. Culture of renal tubular cells from the urine of patients with nephropathic cystinosis. J Am Soc Nephrol 1991; 1:1028-1033.
106. Racusen LC, Wilson PD, Hartz PA, et al. Renal proximal tubular epithelium from patients with nephropathic cystinosis: Immortalized cell lines as in vitro model systems. Kidney Int 1995; 48:536-543.
107. Inoue CN, Kondo Y, Ohnuma S, et al. Use of cultured tubular cells isolated from human urine for investigation of renal transporter. Clin Nephrol 2000; 53:90-98.
108. Erratum in Clin Nephrol 2000; 53(6):492.
109. Laube GF, HaqMR, van't Hoff WG. Exfoliated human proximal tubular cells: a model of cystinosis and Fanconi syndrome. Pediatr Nephrol 2005; 20:136-140.
110. Rahmoune H, Thompson PW, Ward JM, et al. Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with noninsulindependent diabetes. Diabetes 2005; 54:3427-3434.
111. Gildea JJ, Keene SA, Lahiff DT, et al. A novel test for low salt sensitivity: Angiotensin type-II receptor recruitment after dopamine-1 receptor stimulation in urine-derived renal proximal tubule cells. High Blood Pressure Research. 2012 Scientific Sessions, Abstract #495, p. 166.
112. Ross KA. Evidence for somatic gene conversion and deletion in bipolar disorder, Crohn's disease, coronary artery disease, hypertension, rheumatoid arthritis, type-1 diabetes, and type-2 diabetes. BMC Med 2011; 9:12.
113. Esteva-Font C, Wang X, Ars E, et al. Are sodium transporters in urinary exosomes reliable markers of tubular sodium reabsorption in hypertensive patients? Nephron Physiol 2010; 114:25-34.